- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations Investing
- Private Equity
- Real Estate
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Coronavirus
- Crisis Practice
- Environmental Agenda
- Focus on Women's Health
- Special Purpose Acquisition Companies (SPACs)
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
John C. Richter
News 14 results
Recognition
October 13, 2021
Benchmark Litigation Recognizes King & Spalding as a Leading Litigation Firm
Recognition
October 5, 2021
LMG Life Sciences Recognizes King & Spalding With Multiple Rankings in its 2021 Guide
In the News · Source: Law360
May 18, 2021
John Richter advises AT&T on its settlement with the District of Columbia
Recognition
October 23, 2020
GIR Names King & Spalding to List of Top 30 Global Investigations Firms for Sixth Year
Recognition
October 15, 2020
Benchmark Litigation Recognizes King & Spalding as a Leading Litigation Firm
In the News · Source: Risk & Compliance
July 1, 2020
John Richter discusses the False Claims Act and anti-kickbacks in the drug and medical device sector
Recognition
October 4, 2019
LMG Life Sciences Recognizes King & Spalding With Multiple Rankings in its 2019 Guide
Recognition
October 3, 2019
Latest Benchmark Litigation Guides Recognize King & Spalding as a Leading Litigation Firm
In the News · Source: ABA Journal
August 19, 2019
John Richter discusses the impact and scope of the Computer Fraud and Abuse Act
Cases & Deals
May 6, 2019
Michael Behenna Secures Pardon from President Donald J. Trump
Recognition
October 29, 2018
Benchmark Litigation Again Recognizes King & Spalding as a Leading U.S. Litigation Firm
Press Release
November 30, 2016
Law360 Recognizes Four King & Spalding Lawyers as 2016 MVPs